This content is machine translated ESMO in Copenhagen and Singapore Immunotherapy puts lung cancer experts in turmoil Pembrolizumab returned to the international stage of lung cancer therapy with a thunderclap during the presentation of the KEYNOTE 024 trial at the 2016 ESMO Congress in Copenhagen. Lectures on…
View Post 2 min This content is machine translated Bladder Cancer Promising immunotherapy A new phase I trial with a compound targeting the immunosuppressive protein PDL1 shows promising results with a good toxicity profile. This provides a potentially new class of drugs for…
View Post 2 min This content is machine translated Glioblastoma and brain metastases Immune system can be harnessed A study at the ESMO Symposium in Geneva shows: Brain metastases have dense concentrations of tumor-infiltrating lymphocytes, i.e., an immune-active environment. Second, both primary and secondary brain carcinomas cause high…
